MPM Oncology Impact Management GP LLC Insider Profile
11 Followers
MPM Oncology Impact Management GP LLC, former Ten Percent Owner at Viracta Therapeutics, holds 3.33M shares in Viracta Therapeutics (Ticker: VIRX). Most recently, MPM Oncology Impact Management GP LLC Bought 81,500 shares of Viracta Therapeutics on Nov 06, 2017 for an estimated value of $226.00K.
MPM Oncology Impact Management GP LLC's Trading History
You May Also Like
MPM Oncology Impact Management GP LLC insider profile FAQ
What is the percentage of profitable transactions made by MPM Oncology Impact Management GP LLC?
The percentage of profitable transactions made by MPM Oncology Impact Management GP LLC is 0%.
What is the average return per transaction made by MPM Oncology Impact Management GP LLC?
The average return per transaction made by MPM Oncology Impact Management GP LLC is -49.40%.
What stocks does MPM Oncology Impact Management GP LLC hold?
MPM Oncology Impact Management GP LLC holds: VIRX stocks.
What was MPM Oncology Impact Management GP LLC’s latest transaction?
MPM Oncology Impact Management GP LLC’s latest transaction was an Informative Buy of $226.00K.
What was MPM Oncology Impact Management GP LLC's most profitable transaction?
MPM Oncology Impact Management GP LLC’s most profitable transaction was an Informative Buy of VIRX stock on October 31, 2017. The return on the trade was -45.30%.
What is MPM Oncology Impact Management GP LLC's role in Viracta Therapeutics?
MPM Oncology Impact Management GP LLC's role in Viracta Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
